Impel Pharmaceuticals Inc.
IMPLNASDAQHealthcare
$0.04
$-0.02(-27.27%)
Market Cap$956000
P/E Ratio—
52W High$4.2
52W Low$0.0212
Impel Pharmaceuticals Inc.（IMPL）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IMPL · 截至 2026-06-09
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | ($106.31M) | ($76.54M) | ($45.80M) | ($41.86M) |
| Depreciation & Amort. | $1.20M | $1.09M | $1.08M | $0.72M |
| Stock-Based Comp. | $5.19M | $3.13M | $3.64M | $0.79M |
| Change in Working Capital | ($13.01M) | $2.21M | $1.54M | $3.21M |
| Net Cash from Operations | ($93.64M) | ($66.36M) | ($39.18M) | ($36.49M) |
| Investing Activities | ||||
| Capital Expenditure | ($1.38M) | ($0.41M) | ($1.78M) | ($1.52M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($1.38M) | ($0.41M) | ($1.78M) | ($1.52M) |
| Financing Activities | ||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $67.46M | $147.89M | $11.06M | $0.02M |
| Free Cash Flow | ||||
| Free Cash Flow | ($95.02M) | ($66.77M) | ($40.97M) | ($38.01M) |
| FCF Margin %(computed) | -751.02% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Impel Pharmaceuticals Inc.
关于Impel Pharmaceuticals Inc.（IMPL）现金流量表
Impel Pharmaceuticals Inc. 2022财年经营活动现金流($0.09B)，自由现金流($0.10B)（FCF利润率-751.02%），资本支出($0.00B)。
常见问题
IMPL · 4 问Impel Pharmaceuticals Inc. 2022财年自由现金流($0.10B)，同比down42.3%。
IMPL free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09